Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

CA602 antigen

Known as: CA602 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
A new efficient screening for ovarian cancer based on a combination of two tumor markers, CA602 and CA546, is reported. These two… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
Review
2005
Review
2005
 
Review
1999
Review
1999
 
1998
1998
In this study clinical studies were conducted on galactosyltransferase associated with tumour (GAT) as a newly developed marker… Expand
1994
1994
Serum samples from patients with benign or malignant diseases were measured for the newly developed tumor markers CA54/61 and… Expand
1993
1993
Galactosyltransferase Associated with Tumor (GAT) was clinically studied in cases of ovarian cancer. When two cut-off levels of… Expand
1991
1991
A cell line designated RMG‐II was established from the ascites of a patient with ovarian clear cell carcinoma. The chromosomal… Expand
1990
1990
We investigated the usefulness of CA602, a newly developed serum tumor marker, for ovarian cancer. When the cut-off value was set… Expand